非酒精性脂肪性肝病纤维化评分（NFS）可用于门诊服务，以识别 2 型糖尿病患者除晚期肝纤维化以外的慢性血管并发症。
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes.
机构信息
Department of Pathophysiology and Transplantation Ca' Granda IRCCS Foundation, Policlinico Hospital, University of Milan, Italy.
Department of Pathophysiology and Transplantation Ca' Granda IRCCS Foundation, Policlinico Hospital, University of Milan, Italy.
出版信息
J Diabetes Complications. 2020 Nov;34(11):107684. doi: 10.1016/j.jdiacomp.2020.107684. Epub 2020 Jul 17.
We demonstrate in 351 diabetic patients with steatosis that NAFLD fibrosis score (NFS), a rapid and affordable score to diagnose hepatic fibrosis, identifies patients at higher risk of advanced fibrosis and vascular diabetic complications (especially peripheral neuropathy), pointing NFS as a first-line vascular and hepatic screening in diabetic patients.
我们在 351 名患有脂肪性肝病的糖尿病患者中进行了研究，证明了非酒精性脂肪性肝病纤维化评分（NFS），一种快速且经济实惠的诊断肝纤维化的评分，可以识别出患有晚期纤维化和血管性糖尿病并发症（尤其是周围神经病变）风险较高的患者，表明 NFS 可作为糖尿病患者的一线血管和肝脏筛查方法。
Zotero 插件